Status: Recruiting
REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam
The purpose of this study is to demonstrate safety, effectiveness and benefit-risk profile of ResQFoam for the inhospital treatment of exsanguinating, intraabdominal haemorrhage due to trauma in patients where emergent laparotomy is required.
Participants needed: 40
Trial details
Age: 15+Biological sex: AllType: InterventionalSponsor: Arsenal Medical, Inc.Updated: Nov 10, 2025Locations: 2
Eligibility criteria
Estimated age of 15 years or older (or subject weight estimated at greater than... [+11]
Known or suspected major diaphragm injury [+16]